Bayer AGCHIX:BAYND 64 OCF Yield % is 13.86 as of Jun. 24, 2026, which is 19% above its 10-year median of 11.62. GuruFocus rates CHIX:BAYND with a GF Score™ of 64/100 and a GF Value™ of €27.44 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 1,005 Drug Manufacturers companies, Bayer AG ranks better than 86.97% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Bayer AG OCF Yield % Related Terms
Bayer AG OCF Yield % Historical Data
* Premium members only.
The historical data trend for Bayer AG's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:BAYND vs LLY, JNJ, ABBV: OCF Yield % Comparison
For the Drug Manufacturers - General subindustry, Bayer AG's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bayer AG OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Bayer AG's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Bayer AG's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bayer AG (CHIX:BAYND) has a OCF Yield % of 13.86 as of Jun. 24, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Bayer AG and its competitors. This is 19% above median its historical median of 11.62. Over the past decade, Bayer AG's OCF Yield % has ranged from 3.86 to 43.07. According to the industry distribution chart, Bayer AG ranks #131 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 13%.
Is Bayer AG's OCF Yield % too high?
Bayer AG's current OCF Yield % of 13.86 is 19% above median its 10-year median of 11.62. Over the past 10 years, this metric has ranged from a low of 3.86 to a high of 43.07. The Drug Manufacturers industry median OCF Yield % is 3.54. Bayer AG's value of 13.86 is 291.5% above this industry median. Based on the distribution chart, Bayer AG ranks #131 out of 1005 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Bayer AG has a GF Score™ of 64/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bayer AG's OCF Yield % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Bayer AG ranks #131 out of 1005 companies for OCF Yield %. This places Bayer AG in the top 13% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 3.54. Bayer AG's value of 13.86 is 291.5% above this benchmark. Historically, Bayer AG's own OCF Yield % has ranged from 3.86 to 43.07 over the past decade. While the company's 10-year median is 11.62 vs. the industry median of 3.54, Bayer AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.54, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bayer AG's current OCF Yield % of 13.86 is 291.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Bayer AG and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bayer AG's current OCF Yield % is 13.86, which is 19% above median its own 10-year median of 11.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bayer AG stock overvalued right now?
Based on GuruFocus' analysis, Bayer AG (CHIX:BAYND) is currently considered Significantly Overvalued. The stock's GF Value™ is €27.44, compared to a current price of €38.15 — trading 39% above its estimated fair value. The current OCF Yield % is 13.86, which is 19% above median its 10-year median of 11.62 and 291.5% above the Drug Manufacturers industry median of 3.54. Bayer AG's overall GF Score™ is 64/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Bayer AG (CHIX:BAYND), the current OCF Yield % is 13.86 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bayer AG (CHIX:BAYND) Overvalued in 2026?
Based on GuruFocus' analysis, Bayer AG stock appears to be overvalued.
The current stock price of €38.15 is trading 39% above its estimated GF Value™ of €27.44.
GuruFocus considers Bayer AG to be Significantly Overvalued.
Key valuation signals for CHIX:BAYND:
OCF Yield %: 13.86 (19% above median its 10-year median of 11.62)
GF Value™: €27.44 vs. price of €38.15 (39% above fair value)
Industry Position: 291.5% above the Drug Manufacturers median (#131 of 1005)
No single metric tells the full story. See the CHIX:BAYND stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs (about 38% of total sales in 2025) as well as vitamins and other consumer healthcare products (13% of total). The firm's crop science business (47% of total) sells seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.
64GF Score
Get the complete analysis for CHIX:BAYND
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:BAYND has been successfully added to your 
